Saranac Partners LTD Johnson & Johnson Transaction History
Saranac Partners LTD
- $552 Billion
- Q3 2025
A detailed history of Saranac Partners LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Saranac Partners LTD holds 1,482 shares of JNJ stock, worth $295,777. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,482Holding current value
$295,777% of portfolio
0.05%Shares
2 transactions
Others Institutions Holding JNJ
# of Institutions
4,824Shares Held
1.74BCall Options Held
19.8MPut Options Held
16.8M-
Vanguard Group Inc Valley Forge, PA237MShares$47.2 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY198MShares$39.6 Billion0.67% of portfolio
-
State Street Corp Boston, MA132MShares$26.4 Billion0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY58.6MShares$11.7 Billion0.72% of portfolio
-
Geode Capital Management, LLC Boston, MA56.2MShares$11.2 Billion0.69% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $522B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...